ANDRES
VALDIVIESO LOPEZ
Investigador/a en el periodo 2009-2023
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadoras/es de Complexo Hospitalario Universitario de Santiago (8)
2024
2019
-
A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain
Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567
2017
-
Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy
Clinical Transplantation, Vol. 31, Núm. 6
2016
-
Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))
Journal of Hepatology
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
2015
-
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100
2014
-
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study
Journal of Hepatology, Vol. 61, Núm. 5, pp. 1020-1028
2011
-
Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial
Liver Transplantation, Vol. 17, Núm. 2, pp. 167-177